Tranexamic Acid 500mg + Etamsylate 250mg Tablets

Tranexamic Acid 500mg + Etamsylate 250mg tablet combines an antifibrinolytic with a haemostatic agent for selected bleeding conditions, including heavy menstrual bleeding where prescribed. The cause of abnormal bleeding still needs assessment.
Take the tablets during the bleeding period according to the specifically prescribed course. Treatment timing and duration depend on the bleeding disorder; it is not a continuous contraceptive regimen.
Tranexamic acid inhibits plasminogen activation and slows fibrin-clot breakdown; etamsylate supports primary haemostasis and capillary stability.
Nausea, abdominal discomfort, diarrhoea or headache may occur.
A history of thrombosis, visual disturbance, kidney impairment and combined hormonal contraception needs review. Blood in urine and unexplained bleeding require evaluation before treatment.
Can reduce excessive blood loss by supporting clot persistence and haemostasis.
No. It reduces bleeding during the treated episode rather than suppressing the menstrual cycle.
No. It does not prevent pregnancy.
Investigate the cause rather than repeatedly treating unexplained bleeding.
The combination may increase clot risk and needs specific prescriber review.
Yes. Tranexamic acid is cleared by the kidneys and may need adjustment.
Seek urgent assessment for a possible blood clot.
Yes. Stop treatment and obtain prompt assessment for visual changes.
No. Reducing blood loss and replacing depleted iron are separate treatment needs.
Fibrinolysis: breakdown of a fibrin clot. Haemostasis: the process that stops bleeding. Menorrhagia: unusually heavy menstrual bleeding.; AR: Tranexamic Acid 500mg + Etamsylate 250mg أقراص; FR: Tranexamic Acid 500mg + Etamsylate 250mg comprimés; PT: Tranexamic Acid 500mg + Etamsylate 250mg comprimidos; ES: Tranexamic Acid 500mg + Etamsylate 250mg comprimidos; RU: Tranexamic Acid 500mg + Etamsylate 250mg таблетки; ID: Tranexamic Acid 500mg + Etamsylate 250mg tablet; VI: Tranexamic Acid 500mg + Etamsylate 250mg viên nén; MS: Tranexamic Acid 500mg + Etamsylate 250mg tablet; TL: Tranexamic Acid 500mg + Etamsylate 250mg tableta; ZH-SG: Tranexamic Acid 500mg + Etamsylate 250mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Tranexamic Acid 500mg + Etamsylate 250mg Tablets under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Tranexamic Acid 500mg + Etamsylate 250mg Tablets